Ainos Begins Clinical Study of Smell AI Technology at National Taiwan University Hospital

Ainos, Inc. has initiated a clinical study at the National Taiwan University Hospital (NTUH) to evaluate the application of its “Smell AI” technology within healthcare infrastructure. The research project aims to assess the efficacy of the company’s volatile organic compound (VOC) sensing platform in identifying specific health indicators in clinical settings.

The study utilizes Ainos’ proprietary sensor technology, which detects and analyzes airborne chemical signatures. Researchers at NTUH are currently testing the system’s ability to integrate with existing hospital monitoring protocols to determine if the technology can provide reliable data for diagnostic support. This collaboration marks a shift for the company as it moves its AI-driven olfactory sensing tools from experimental development into practical, hospital-based environments. The project remains in the data collection phase, with the findings expected to inform future iterations of the company’s medical-grade sensing hardware.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

Author

GOAI